BioCatalyst

Ensifentrine, LABA/LAMA — catalyst calendar

1 verified catalyst event(s) referencing Ensifentrine, LABA/LAMA, each linked to its official source. Verified as of 2026-11-04.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-03-01
in 4mo
ESTIMATED
 READOUT
Effect of Ensifentrine (MK-5884/RPL554) on Sputum Markers of Inflammation in Chr
Phase 2 · Pulmonary Disease, Chronic Obstructive, COPD
 Verona Pharma, Inc., a subsidiary Ensifentrine, LABA/LAMA ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.